PRIMARY VISCERAL LEISHMANIASIS
Clinical trials for PRIMARY VISCERAL LEISHMANIASIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY VISCERAL LEISHMANIASIS trials appear
Sign up with your email to follow new studies for PRIMARY VISCERAL LEISHMANIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Kala-Azar: experimental drug shows promise in ethiopia
Disease control CompletedThis study tested a new drug called LXE408 for people with primary visceral leishmaniasis, a serious parasitic disease. Fifty-two adults in Ethiopia received either LXE408 or standard treatment. The main goal was to see if the drug could cure the infection by day 28, meaning symp…
Matched conditions: PRIMARY VISCERAL LEISHMANIASIS
Phase: PHASE2 • Sponsor: Drugs for Neglected Diseases • Aim: Disease control
Last updated May 26, 2026 03:29 UTC
-
New pill shows promise against deadly parasitic disease
Disease control CompletedThis study tested a new oral drug, LXE408, in 101 adults and adolescents with primary visceral leishmaniasis, a serious parasitic infection. Participants received one of two LXE408 regimens or a standard intravenous treatment. The goal was to see if LXE408 could safely clear the …
Matched conditions: PRIMARY VISCERAL LEISHMANIASIS
Phase: PHASE2 • Sponsor: Drugs for Neglected Diseases • Aim: Disease control
Last updated May 22, 2026 13:54 UTC